Walleye Capital’s Satsuma Pharmaceuticals STSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-93,672
Closed -$562K – 3810
2022
Q3
$562K Sell
93,672
-57,756
-38% -$328K 0.01% 1382
2022
Q2
$627K Sell
151,428
-110,385
-42% -$389K 0.02% 909
2022
Q1
$995K Buy
+261,813
New +$1.18M 0.03% 639

Other funds holding STSA

Walleye Capital's STSA Position: Q4 2022 in Review

Walleye Capital sold out of Satsuma Pharmaceuticals (STSA) in Q4 2022, closing a stake of 93,672 shares — an estimated $562K sold.

Walleye Capital first reported a position in STSA in Q1 2022 and held it in 3 quarters. The position peaked at $995K in Q1 2022. 33 funds tracked by Wall St. Rank hold STSA as of Q4 2022.

  • Walleye Capital reported no remaining Satsuma Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Walleye Capital sold 93,672 Satsuma Pharmaceuticals shares in Q4 2022, an estimated $562K.
  • Walleye Capital first reported a position in Satsuma Pharmaceuticals in Q1 2022 and held it in 3 quarters.
  • Walleye Capital's Satsuma Pharmaceuticals position peaked at $995K in Q1 2022.
  • 33 funds tracked by Wall St. Rank held Satsuma Pharmaceuticals as of Q4 2022.

Based on Walleye Capital's 13F filing for Q4 2022, filed 14 Feb 2023.